AU2020361080A1 - Bone marrow mesenchymal stem cell derived cell populations and methods of preparing same - Google Patents

Bone marrow mesenchymal stem cell derived cell populations and methods of preparing same Download PDF

Info

Publication number
AU2020361080A1
AU2020361080A1 AU2020361080A AU2020361080A AU2020361080A1 AU 2020361080 A1 AU2020361080 A1 AU 2020361080A1 AU 2020361080 A AU2020361080 A AU 2020361080A AU 2020361080 A AU2020361080 A AU 2020361080A AU 2020361080 A1 AU2020361080 A1 AU 2020361080A1
Authority
AU
Australia
Prior art keywords
cells
mscs
medicament
timp
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020361080A
Other languages
English (en)
Inventor
Anthony Peter Hollander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liverpool
Original Assignee
University of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liverpool filed Critical University of Liverpool
Publication of AU2020361080A1 publication Critical patent/AU2020361080A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2020361080A 2019-10-02 2020-10-02 Bone marrow mesenchymal stem cell derived cell populations and methods of preparing same Pending AU2020361080A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1914235.5 2019-10-02
GB201914235A GB201914235D0 (en) 2019-10-02 2019-10-02 Cell populations and methods of preparing same
PCT/GB2020/052439 WO2021064424A1 (en) 2019-10-02 2020-10-02 Bone marrow mesenchymal stem cell derived cell populations and methods of preparing same

Publications (1)

Publication Number Publication Date
AU2020361080A1 true AU2020361080A1 (en) 2022-05-26

Family

ID=68538920

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020361080A Pending AU2020361080A1 (en) 2019-10-02 2020-10-02 Bone marrow mesenchymal stem cell derived cell populations and methods of preparing same

Country Status (7)

Country Link
US (1) US20220389386A1 (https=)
EP (1) EP4038179B1 (https=)
JP (1) JP7710242B2 (https=)
KR (1) KR20220092880A (https=)
AU (1) AU2020361080A1 (https=)
GB (1) GB201914235D0 (https=)
WO (1) WO2021064424A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113881707B (zh) * 2021-10-25 2023-07-14 中国人民解放军军事科学院军事医学研究院 调控脐带间充质干细胞免疫抑制作用的产品、方法及用途
CN117919220A (zh) * 2024-02-05 2024-04-26 南通大学附属医院 紫杉醇在制备促进肌腱细胞增殖药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009058983A2 (en) * 2007-10-30 2009-05-07 University Of Louisville Research Foundation, Inc. Subpopulations of bone marrow-derived adherent stem cells and methods of use therefor
WO2013067038A1 (en) * 2011-11-01 2013-05-10 Neostem, Inc. Adult mesenchymal stem cell (msc) compositions and methods for preparing the same
JP7168653B2 (ja) * 2017-08-16 2022-11-09 スンクワン メディカル ファウンデーション 間葉系幹細胞を含む甲状腺眼症を治療するための組成物

Also Published As

Publication number Publication date
EP4038179A1 (en) 2022-08-10
JP7710242B2 (ja) 2025-07-18
JP2022551103A (ja) 2022-12-07
US20220389386A1 (en) 2022-12-08
EP4038179B1 (en) 2026-04-22
GB201914235D0 (en) 2019-11-13
KR20220092880A (ko) 2022-07-04
WO2021064424A1 (en) 2021-04-08

Similar Documents

Publication Publication Date Title
EP2120977B1 (en) Treatment of inflammatory diseases using placental stem cells
Veréb et al. Role of human corneal stroma-derived mesenchymal-like stem cells in corneal immunity and wound healing
EP3600354B1 (en) Generation of therapeutic cells using extracellular components of target organs
Salerno et al. MMP13 and TIMP1 are functional markers for two different potential modes of action by mesenchymal stem/stromal cells when treating osteoarthritis
JP6628253B2 (ja) 細胞の適性を判定する方法
US20190030081A1 (en) Mesenchymal stem cells with enhanced efficacy
RU2576836C2 (ru) Лечение заболевания периферических сосудов при помощи клеток, полученных из ткани пуповины
CN104127438A (zh) 间充质干细胞颗粒
US20210095254A1 (en) Highly functional manufactured stem cells
EP3294904B1 (en) Methods for assesing the purity of a mesenchymal stem cells preparation
EP3336176A1 (en) Improved umbilical cord-derived adhesive stem cells, preparation method therefor, and use thereof
US20180142211A1 (en) Methods of mesenchymal stem cell mobilization and expansion
EP3669884B1 (en) Composition for treatment of thyroid associated ophthalmopathy, comprising mesenchymal stem cell
EP4038179B1 (en) Bone marrow mesenchymal stem cell derived cell populations and methods of preparing same
Del Pup et al. Adrenomedullin is expressed in cord blood hematopoietic cells and stimulates their clonal growth
AU2016349701A1 (en) Enrich and amplify highly potent human mesenchymal stem cells from elderly cell populations
US20230149523A1 (en) Treatment of autoimmunity and transplant rejection through establishment and/or promotion of tolerogenic processes by fibroblast-mediated reprogramming of antigen presenting cells
US20250034528A1 (en) Synchronized mesenchymal stromal cells
Zhao et al. Bone Marrow-and Umbilical Cord-Derived Mesenchymal Stem Cell Secretome Alters Gene Expression and Upregulates Motility of Human Endometrial Stromal Cells
de Pedro et al. Interferon-gamma and TNF-alpha synergistically enhance the immunomodulatory capacity of Endometrial-Derived Mesenchymal Stromal Cell secretomes by differential microRNA and extracellular vesicle release
JP2025535110A (ja) 新規の細胞株および治療におけるそれらの使用
Poudel Ageing of bone marrow derived mesenchyman stem cells in relation to nutrient starvation
HK1251620B (en) Methods for assesing the purity of a mesenchymal stem cells preparation
HK1135328B (en) Treatment of inflammatory diseases using placental stem cells